Pressure continues to mount on federal Health Minister Leona Aglukkaq to take stronger action to solve the burgeoning medication shortage in Canada. Drug shortfalls have been occurring more frequently in the last two to three years, both in Canada and around the world. But recent production cuts by Quebec-based generic pharmaceutical company Sandoz have left even bigger gaps in the drug supply…In Ottawa on Tuesday, NDP health critic Libby Davies accused Aglukkaq in the Commons of failing to take concrete steps to deal with the drug shortage, including making it mandatory for pharmaceutical companies to report production shortfalls for specific products. Such reporting is now voluntary, although drug makers increasingly are reporting shortages in their product lines. “The fact is, this minister has refused to stand up and show the leadership that is required on this crisis,” Davies told the House.